fluoxetine has been researched along with Attention Deficit and Disruptive Behavioral Disorders in 3 studies
Fluoxetine: The first highly specific serotonin uptake inhibitor. It is used as an antidepressant and often has a more acceptable side-effects profile than traditional antidepressants.
fluoxetine : A racemate comprising equimolar amounts of (R)- and (S)-fluoxetine. A selective serotonin reuptake inhibitor (SSRI), it is used (generally as the hydrochloride salt) for the treatment of depression (and the depressive phase of bipolar disorder), bullimia nervosa, and obsessive-compulsive disorder.
N-methyl-3-phenyl-3-[4-(trifluoromethyl)phenoxy]propan-1-amine : An aromatic ether consisting of 4-trifluoromethylphenol in which the hydrogen of the phenolic hydroxy group is replaced by a 3-(methylamino)-1-phenylpropyl group.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hilton, RC | 1 |
| Rengasamy, M | 1 |
| Mansoor, B | 1 |
| He, J | 1 |
| Mayes, T | 1 |
| Emslie, GJ | 1 |
| Porta, G | 1 |
| Clarke, GN | 1 |
| Wagner, KD | 1 |
| Birmaher, B | 1 |
| Keller, MB | 1 |
| Ryan, N | 1 |
| Shamseddeen, W | 1 |
| Asarnow, JR | 1 |
| Brent, DA | 1 |
| Jacobs, RH | 1 |
| Becker-Weidman, EG | 1 |
| Reinecke, MA | 1 |
| Jordan, N | 1 |
| Silva, SG | 1 |
| Rohde, P | 1 |
| March, JS | 1 |
| Storch, DD | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Treatment of SSRI-Resistant Depression in Adolescents (TORDIA)[NCT00018902] | Phase 2/Phase 3 | 334 participants (Actual) | Interventional | 2001-01-31 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
2 trials available for fluoxetine and Attention Deficit and Disruptive Behavioral Disorders
| Article | Year |
|---|---|
Impact of treatments for depression on comorbid anxiety, attentional, and behavioral symptoms in adolescents with selective serotonin reuptake inhibitor-resistant depression.
Topics: Adolescent; Anxiety; Attention Deficit and Disruptive Behavior Disorders; Behavioral Symptoms; Cital | 2013 |
Treating depression and oppositional behavior in adolescents.
Topics: Adolescent; Antidepressive Agents, Second-Generation; Attention Deficit and Disruptive Behavior Diso | 2010 |
1 other study available for fluoxetine and Attention Deficit and Disruptive Behavioral Disorders
| Article | Year |
|---|---|
Medication-induced hypomania in Asperger's disorder.
Topics: Affective Symptoms; Attention Deficit and Disruptive Behavior Disorders; Autistic Disorder; Child; C | 1999 |